What is the prognosis for multiple myeloma?
The prognosis for multiple myeloma may vary according to different factors. In the worst case, the physician may consider irreparable disease and can only provide a matte prognosis as survival. If cancer is caught in an earlier phase, then there is a higher chance of a good prognosis. This may mean that cancer cells have not yet spread, or that any plasmacytomas-the plasma cell-ling-core group-lines are easily removed. Chemotherapy and radiation are common treatment options, but experimental treatment may also be offered. The prognosis for the earliest phase may be positive, but patients are still given an average of 62 months.
If the disease is caught in the second phase, the prognosis may still be positive, but the number of cancer cells is increasing. The average life expectancy is reduced to 45 months and similar treatment can also be performed. The prognosis of multiple myeloma in its third and last stage may beVery discouraging, because cancer cells not only joined, but also spread to different organs. In this final phase, many complications such as red blood cells, increases in blood calcium and fatal progression of plasmacytomas in the bones may occur. Aggressive and experimental treatment can still be performed, but can only be given to patients for two years or less.
Without any treatment, the patient may have a shorter life expectancy of six months. The prognosis of multiple myeloma may also vary if cancer is active or inactive. Active diagnosis, usually in the first two stages, means that the patient is experiencing symptoms of message and should be treated as soon as possible. A patient with an inactive multiple myelomemnevevy commands no warning signals and cancer has slower growth. In this case, the patient can live for up to 10 years, with certain treatments to keep cancer at bay.
Other factors that affect the prognosis of multiple myeloma, include patient health, age and initial reaction to treatment. PermanentThe multi -specific antibodies can also increase the chances of recovery. Any damage on the other side of vital organs such as kidney and liver can lead to negative prognosis. If cancer is repeated, life expectancy is also reduced.